351 related articles for article (PubMed ID: 28327181)
1. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.
Arbel-Ornath M; Hudry E; Boivin JR; Hashimoto T; Takeda S; Kuchibhotla KV; Hou S; Lattarulo CR; Belcher AM; Shakerdge N; Trujillo PB; Muzikansky A; Betensky RA; Hyman BT; Bacskai BJ
Mol Neurodegener; 2017 Mar; 12(1):27. PubMed ID: 28327181
[TBL] [Abstract][Full Text] [Related]
2. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
3. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
Nimmrich V; Ebert U
Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
[TBL] [Abstract][Full Text] [Related]
4. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
[TBL] [Abstract][Full Text] [Related]
5. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
[TBL] [Abstract][Full Text] [Related]
6. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
Elife; 2017 Jul; 6():. PubMed ID: 28696204
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
[TBL] [Abstract][Full Text] [Related]
8. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
9. Synaptic changes in Alzheimer's disease and its models.
Pozueta J; Lefort R; Shelanski ML
Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
[TBL] [Abstract][Full Text] [Related]
10. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
12. Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer's disease.
Bai Y; Li M; Zhou Y; Ma L; Qiao Q; Hu W; Li W; Wills ZP; Gan WB
Mol Neurodegener; 2017 Nov; 12(1):86. PubMed ID: 29137651
[TBL] [Abstract][Full Text] [Related]
13. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
[TBL] [Abstract][Full Text] [Related]
15. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.
Zhang H; Sun S; Wu L; Pchitskaya E; Zakharova O; Fon Tacer K; Bezprozvanny I
J Neurosci; 2016 Nov; 36(47):11837-11850. PubMed ID: 27881772
[TBL] [Abstract][Full Text] [Related]
16. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
17. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
[TBL] [Abstract][Full Text] [Related]
18. Rapid, reversible impairment of synaptic signaling in cultured cortical neurons by exogenously-applied amyloid-β.
Lee S; Zemianek J; Shea TB
J Alzheimers Dis; 2013; 35(2):395-402. PubMed ID: 23403533
[TBL] [Abstract][Full Text] [Related]
19. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
